As T-cell lymphomas are not included in TCGA, there have been no comprehensive studies of mutational signatures in T-cell NHL although recent high-throughput sequencing studies have identified putative driver gene mutations targeting specific signalling pathways notably TCR, NF-kB and JAK-STAT signalling10–14. Here, NFKB1 is linked to T-cell non-Hodgkin lymphoma.